Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fructose | 10 | 2021 | 62 | 5.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 14 | 2025 | 177 | 3.040 |
Why?
|
| Glucose | 12 | 2023 | 878 | 2.450 |
Why?
|
| Lipogenesis | 11 | 2025 | 56 | 2.120 |
Why?
|
| Liver | 12 | 2025 | 1749 | 1.920 |
Why?
|
| Transcription Factors | 9 | 2025 | 2593 | 1.620 |
Why?
|
| Nuclear Proteins | 8 | 2022 | 1265 | 1.560 |
Why?
|
| Insulin | 14 | 2021 | 1203 | 1.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2022 | 1271 | 1.150 |
Why?
|
| Insulin Resistance | 11 | 2022 | 641 | 1.010 |
Why?
|
| Triglycerides | 4 | 2022 | 575 | 0.840 |
Why?
|
| Lipase | 2 | 2021 | 93 | 0.840 |
Why?
|
| Succinic Acid | 1 | 2022 | 14 | 0.810 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 398 | 0.770 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 152 | 0.750 |
Why?
|
| Systems Analysis | 1 | 2021 | 15 | 0.750 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 67 | 0.730 |
Why?
|
| Homeostasis | 6 | 2023 | 703 | 0.690 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 104 | 0.690 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 174 | 0.680 |
Why?
|
| Animals | 31 | 2025 | 34241 | 0.670 |
Why?
|
| Adipose Tissue | 3 | 2014 | 465 | 0.670 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 130 | 0.670 |
Why?
|
| Blood Glucose | 8 | 2025 | 1132 | 0.660 |
Why?
|
| Fructose Intolerance | 2 | 2017 | 3 | 0.620 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 106 | 0.620 |
Why?
|
| Adipocytes | 3 | 2015 | 141 | 0.620 |
Why?
|
| Obesity | 11 | 2022 | 2252 | 0.610 |
Why?
|
| Intestine, Small | 1 | 2021 | 307 | 0.600 |
Why?
|
| Mice | 20 | 2025 | 17637 | 0.580 |
Why?
|
| Insulin-Secreting Cells | 4 | 2022 | 148 | 0.560 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 553 | 0.550 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2021 | 77 | 0.510 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1527 | 0.510 |
Why?
|
| Thermogenesis | 1 | 2015 | 46 | 0.480 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 702 | 0.470 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 343 | 0.450 |
Why?
|
| Energy Metabolism | 4 | 2025 | 766 | 0.440 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 1689 | 0.410 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 778 | 0.400 |
Why?
|
| Mice, Knockout | 6 | 2022 | 3746 | 0.370 |
Why?
|
| Signal Transduction | 4 | 2016 | 4536 | 0.360 |
Why?
|
| Fatty Liver | 3 | 2025 | 188 | 0.350 |
Why?
|
| Proteins | 1 | 2015 | 1036 | 0.340 |
Why?
|
| Humans | 35 | 2025 | 125392 | 0.320 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 2522 | 0.300 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 175 | 0.300 |
Why?
|
| Lipid Metabolism | 3 | 2025 | 357 | 0.300 |
Why?
|
| Dyslipidemias | 2 | 2022 | 234 | 0.300 |
Why?
|
| Fatty Acids | 2 | 2025 | 344 | 0.290 |
Why?
|
| Acetyl Coenzyme A | 2 | 2025 | 13 | 0.290 |
Why?
|
| Glycolysis | 2 | 2016 | 150 | 0.250 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 3 | 2022 | 8 | 0.250 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 358 | 0.240 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1711 | 0.230 |
Why?
|
| Lipids | 2 | 2023 | 523 | 0.220 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2025 | 122 | 0.220 |
Why?
|
| Adiposity | 2 | 2018 | 190 | 0.220 |
Why?
|
| Glucose Intolerance | 2 | 2016 | 78 | 0.220 |
Why?
|
| Male | 20 | 2025 | 61663 | 0.210 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2014 | 19 | 0.210 |
Why?
|
| Weight Loss | 4 | 2022 | 482 | 0.200 |
Why?
|
| Succinates | 1 | 2022 | 20 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2021 | 2640 | 0.200 |
Why?
|
| Lipoproteins | 2 | 2022 | 180 | 0.200 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 47 | 0.200 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2022 | 27 | 0.200 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 2 | 2021 | 10 | 0.200 |
Why?
|
| Body Weight | 2 | 2019 | 989 | 0.190 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 115 | 0.190 |
Why?
|
| Hexoses | 1 | 2021 | 11 | 0.180 |
Why?
|
| Keto Acids | 1 | 2021 | 56 | 0.180 |
Why?
|
| Metabolomics | 1 | 2025 | 423 | 0.180 |
Why?
|
| Rodentia | 1 | 2021 | 45 | 0.180 |
Why?
|
| RNA, Messenger | 2 | 2021 | 2820 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 817 | 0.180 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 57 | 0.180 |
Why?
|
| Dietary Sugars | 1 | 2021 | 16 | 0.180 |
Why?
|
| Cohort Studies | 4 | 2021 | 4824 | 0.180 |
Why?
|
| Fasting | 3 | 2017 | 294 | 0.170 |
Why?
|
| Female | 18 | 2025 | 66885 | 0.170 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 842 | 0.170 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 5 | 0.170 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 120 | 0.170 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 17 | 0.170 |
Why?
|
| Food Deprivation | 1 | 2020 | 32 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 4406 | 0.170 |
Why?
|
| Haplotypes | 1 | 2021 | 522 | 0.170 |
Why?
|
| Hepatocytes | 2 | 2022 | 211 | 0.170 |
Why?
|
| Lipoproteins, VLDL | 2 | 2018 | 58 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 184 | 0.160 |
Why?
|
| Glucosides | 1 | 2020 | 47 | 0.160 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 66 | 0.160 |
Why?
|
| Terminology as Topic | 1 | 2021 | 223 | 0.160 |
Why?
|
| Mice, Inbred Strains | 1 | 2019 | 308 | 0.160 |
Why?
|
| Cholesterol | 2 | 2022 | 541 | 0.160 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 351 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 358 | 0.160 |
Why?
|
| Transcriptome | 1 | 2025 | 955 | 0.150 |
Why?
|
| Intestines | 1 | 2022 | 577 | 0.150 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Carboxypeptidases A | 1 | 2018 | 4 | 0.150 |
Why?
|
| Colon | 1 | 2021 | 351 | 0.150 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 8 | 0.150 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.150 |
Why?
|
| Gastrectomy | 1 | 2019 | 93 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 14 | 0.150 |
Why?
|
| Pharmacogenomic Variants | 1 | 2018 | 35 | 0.150 |
Why?
|
| Sugars | 1 | 2018 | 15 | 0.150 |
Why?
|
| Machine Learning | 1 | 2021 | 251 | 0.150 |
Why?
|
| Sweetening Agents | 1 | 2017 | 34 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 114 | 0.140 |
Why?
|
| Beverages | 1 | 2017 | 100 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2021 | 875 | 0.130 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2016 | 18 | 0.130 |
Why?
|
| Eye Proteins | 1 | 2018 | 218 | 0.130 |
Why?
|
| Diet | 2 | 2021 | 1140 | 0.130 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2016 | 90 | 0.130 |
Why?
|
| Metformin | 1 | 2018 | 151 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2017 | 699 | 0.120 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2015 | 403 | 0.120 |
Why?
|
| Esters | 1 | 2014 | 31 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 3160 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2021 | 3468 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 558 | 0.110 |
Why?
|
| Phenotype | 2 | 2021 | 4263 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 226 | 0.110 |
Why?
|
| Rats | 4 | 2025 | 3727 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 867 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 576 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 43 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 107 | 0.090 |
Why?
|
| Risk Factors | 3 | 2025 | 10331 | 0.090 |
Why?
|
| Vitamin D | 1 | 2012 | 162 | 0.090 |
Why?
|
| Genotype | 2 | 2018 | 2568 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2015 | 3056 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 50 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 31 | 0.080 |
Why?
|
| Adult | 9 | 2025 | 29692 | 0.080 |
Why?
|
| Protein Phosphatase 2C | 2 | 2021 | 54 | 0.080 |
Why?
|
| Middle Aged | 9 | 2021 | 26990 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3583 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2012 | 1568 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1331 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 494 | 0.080 |
Why?
|
| Leptin | 1 | 2010 | 214 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2022 | 6168 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1328 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1318 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 571 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 5849 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3892 | 0.070 |
Why?
|
| Cadaver | 2 | 2018 | 132 | 0.070 |
Why?
|
| Oxygen | 1 | 2010 | 557 | 0.060 |
Why?
|
| Carbon | 1 | 2006 | 92 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2018 | 381 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 356 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 502 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4396 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1461 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3350 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 724 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 875 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3440 | 0.050 |
Why?
|
| Natriuretic Peptides | 1 | 2022 | 8 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 5 | 0.050 |
Why?
|
| Palmitates | 1 | 2022 | 19 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 71 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2022 | 70 | 0.050 |
Why?
|
| Particle Size | 1 | 2022 | 124 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 134 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2025 | 435 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1243 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 282 | 0.050 |
Why?
|
| Feedback | 1 | 2022 | 164 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 162 | 0.040 |
Why?
|
| Massachusetts | 1 | 2020 | 125 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 79 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2018 | 2314 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2021 | 330 | 0.040 |
Why?
|
| Body Composition | 2 | 2012 | 521 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 180 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 16 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 208 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 41 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 55 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 69 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 44 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 101 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 156 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 129 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2018 | 165 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 286 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 211 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 305 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 294 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2017 | 71 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2016 | 6 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 221 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1329 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 997 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 50 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 733 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2015 | 50 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2015 | 24 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 686 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 772 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 185 | 0.030 |
Why?
|
| Aged | 3 | 2018 | 19896 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 70 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 571 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1638 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 686 | 0.030 |
Why?
|
| Adolescent | 2 | 2025 | 19373 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 806 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 332 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 352 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2397 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 3154 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1442 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2011 | 18 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 292 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 535 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1410 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 85 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 169 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 779 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 73 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 422 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 384 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 145 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9069 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3096 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1615 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2077 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6345 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 486 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 1435 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2917 | 0.020 |
Why?
|
| Metabolome | 1 | 2010 | 293 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1446 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6607 | 0.020 |
Why?
|
| Child | 1 | 2025 | 24436 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12412 | 0.010 |
Why?
|
| United States | 1 | 2016 | 10936 | 0.010 |
Why?
|